B

Bionano Genomics, Inc.

325 employees

BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins.

Basic info

Industry

biotechnology research

Sectors

Human Genetics
Biotechnology
Long Molecules
Translocations
Indels
Sequence Finishing
Genomics
Genome Mapping
Structural Variation
De Novo Assembly
Rare Diseases
Next Generation Cytogenetics
Copy Number Variation
Health Diagnostics
Biomarker Discovery
Genetics
Hybrid Scaffolding
Cancer Research
Medical
Linearizing DNA
Single-Molecule Imaging

Date founded

2003

Funding rounds raised

Total raised

$53M

from 14 investors over 14 rounds

B

Bionano Genomics, Inc. raised $32M on August 1, 2016

Investors: Domain Associates and LC Ventures

B

Bionano Genomics, Inc. raised $9.9M on March 1, 2016

Investors: Legend Capital and Domain Associates

B

Bionano Genomics, Inc. raised $53M on November 20, 2014

Investors: Collins Ventures, Domain Associates and Legend Capital

B

Bionano Genomics, Inc. raised $10M on October 2, 2013

Investors: Collins Ventures and Domain Associates

B

Bionano Genomics, Inc. raised $10M on July 6, 2012

Investors: Collins Ventures and Domain Associates

B

Bionano Genomics, Inc. raised $23M on March 17, 2011

Investors: Collins Ventures, KT Venture Group and Domain Associates

FAQ